Structural and functional characterization of the NHR2 and Runt domains of AML1/ETO.

被引：0
|
作者：
Cheney, MD
Liu, YZ
Zhou, YP
Chruszcz, M
Laue, TM
Minor, W
Bushweller, JH
Speck, NA
机构：
[1] Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH USA
[2] Univ Virginia, Dept Mol Physiol & Biophys, Charlottesville, VA 22903 USA
[3] Univ New Hampshire, Dept Biochem, Durham, NH 03824 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
482
引用
收藏
页码：141A / 141A
页数：1
相关论文
共 50 条
  • [1] Structural and functional characterization of the NHR2 and Runt domains of AML1/ETO
    Cheney, MD
    Liu, YZ
    Gaudet, JJ
    Chruszcz, M
    Lukasik, SM
    Sugiyama, D
    Lary, J
    Cole, J
    Dauter, Z
    Minor, W
    Speck, NA
    Bushweller, JH
    BLOOD, 2005, 106 (11) : 800A - 800A
  • [2] The NHR2 oligomerization domain of AML1/ETO as a novel therapeutic target structure in t(8;21) positive leukemias
    Wichmann, Christian
    Becker, Yvonne
    Grez, Manuel
    BLOOD, 2007, 110 (11) : 69A - 69A
  • [3] RUNX1/AML1 DNA binding domain and ETO/MTG8 NHR2 dimerization domain are critical to AML1-ETO9a leukemogenesis.
    Yan, Ming
    Hiebert, Scott
    Zhang, Dong-Er
    BLOOD, 2006, 108 (11) : 232A - 232A
  • [4] Genetic dissection of leukemogenesis-related genes/pathways cooperating with AML1/ETO.
    Yin, B
    Largaespada, DA
    Downing, JR
    BLOOD, 2005, 106 (11) : 457A - 457A
  • [5] Targeting the NHR2 oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity
    Wichmann, C.
    Grez, M.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 83 - 84
  • [6] Demonstration of physical and functional interactions of AML1 and AML1/ETO with an ETS protein, MEF.
    Mao, S
    Miyazaki, Y
    Zhang, J
    Nimer, SD
    BLOOD, 1997, 90 (10) : 180 - 180
  • [7] NHR4 domain mutations of ETO are probably very infrequent in AML1–ETO positive myeloid leukemia cells
    B Hackanson
    M Abdelkarim
    J H Jansen
    M Lübbert
    Leukemia, 2010, 24 : 860 - 861
  • [8] RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis
    Yan, Ming
    Ahn, Eun-Young
    Hiebert, Scott W.
    Zhang, Dong-Er
    BLOOD, 2009, 113 (04) : 883 - 886
  • [9] The ubiquitin-ligase APC-Cdh1 is required for maintaining genomic stability and is transcriptional repressed by AML1/ETO.
    Waesch, R
    Engelbert, D
    Schnerch, D
    BLOOD, 2005, 106 (11) : 460A - 460A
  • [10] Multiple functional domains of AML1:: PU.1 and C/EBPα synergize with different regions of AML1
    Petrovick, HS
    Hiebert, SW
    Friedman, AD
    Hetherington, CJ
    Tenen, DG
    Zhang, DE
    MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (07) : 3915 - 3925
12345